High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity

Prostate-Specific Membrane Antigen as a Potential Novel Vascular Target for Treatment of Glioblastoma Multiforme

(2011) A Gabriella Wernicke et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature

(2011) Mary K Samplaski et al.   MODERN PATHOLOGY

Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression

(2011) Lihong Yin et al.   PLoS One

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen

(2011) M. J. Evans et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anti-prostate-Specific membrane antigen-based radioimmunotherapy for prostate cancer

(2010) Scott T. Tagawa et al.   CANCER

Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA)

(2010) Sachin S. Chandran et al.   CANCER BIOLOGY & THERAPY

Adenovirus Targeting to Prostate-Specific Membrane Antigen through Virus-Displayed, Semirandom Peptide Library Screening

(2010) P. Wu et al.   CANCER RESEARCH

Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen

(2009) U. Elsasser-Beile et al.   CURRENT DRUG TARGETS

Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers

(2009) Michael C. Haffner et al.   HUMAN PATHOLOGY

Prostate-specific membrane antigen expression in regeneration and repair

(2008) Ilyssa O Gordon et al.   MODERN PATHOLOGY